SIMILAR PATTERNS OF AMINO ACIDS FOR 6MXT_A_K5YA1401_0

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a88 CHLOROPEROXIDASE L

(Streptomyces
lividans) 		PF00561
(Abhydrolase_1) 		5 VAL A 228
VAL A 229
ASP A 143
PHE A 145
PHE A 202
 None
 1.39A 6mxtA-1a88A:
undetectable		 6mxtA-1a88A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ffv CUTL, MOLYBDOPROTEIN
OF CARBON MONOXIDE
DEHYDROGENASE

(Hydrogenophaga
pseudoflava) 		PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2) 		5 VAL B 755
ASP B 739
PHE B 480
TYR B 656
ILE B 655
 PCD  B1920 (-4.1A)
None
None
None
None
 1.35A 6mxtA-1ffvB:
0.0		 6mxtA-1ffvB:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jed SULFATE
ADENYLYLTRANSFERASE

(Saccharomyces
cerevisiae) 		PF01747
(ATP-sulfurylase)
PF14306
(PUA_2) 		5 VAL A 500
VAL A 499
PHE A 422
PHE A 396
TYR A 428
 None
 1.46A 6mxtA-1jedA:
0.0		 6mxtA-1jedA:
22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ni3 YCHF GTP-BINDING
PROTEIN

(Schizosaccharomyces
pombe) 		PF01926
(MMR_HSR1)
PF06071
(YchF-GTPase_C) 		5 VAL A  63
VAL A  89
PHE A  36
ILE A 263
TYR A 120
 None
 1.14A 6mxtA-1ni3A:
0.0		 6mxtA-1ni3A:
24.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9v HLA CLASS II
HISTOCOMPATIBILITY
ANTIGEN, DQ(3) ALPHA
CHAIN

(Homo sapiens) 		PF00993
(MHC_II_alpha)
PF07654
(C1-set) 		5 PHE A  58
HIS A  24
TYR A  22
ILE A  63
ASN A  62
 EDO  A 501 (-4.6A)
EDO  A 504 (-4.3A)
None
None
None
 1.29A 6mxtA-1s9vA:
0.0		 6mxtA-1s9vA:
17.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5b 3-ISOPROPYLMALATE
DEHYDROGENASE

(Bacillus
coagulans) 		PF00180
(Iso_dh) 		5 VAL A 321
VAL A 324
ASP A  19
ASN A 292
ILE A 345
 None
 1.24A 6mxtA-1v5bA:
0.6		 6mxtA-1v5bA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w6f ARYLAMINE
N-ACETYLTRANSFERASE

(Mycolicibacterium
smegmatis) 		PF00797
(Acetyltransf_2) 		5 VAL A 269
VAL A 272
ASP A 259
ASN A  40
ILE A  47
 None
 1.40A 6mxtA-1w6fA:
0.0		 6mxtA-1w6fA:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1we5 PUTATIVE FAMILY 31
GLUCOSIDASE YICI

(Escherichia
coli) 		PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2) 		5 VAL A 462
VAL A 477
ASP A 707
PHE A 269
TYR A 574
 None
 1.30A 6mxtA-1we5A:
0.0		 6mxtA-1we5A:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xb2 ELONGATION FACTOR
TS, MITOCHONDRIAL

(Bos taurus) 		PF00889
(EF_TS) 		5 VAL B 151
VAL B 154
PHE B 147
ASN B 135
ILE B 203
 None
 1.37A 6mxtA-1xb2B:
undetectable		 6mxtA-1xb2B:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zye THIOREDOXIN-DEPENDEN
T PEROXIDE REDUCTASE

(Bos taurus) 		PF00578
(AhpC-TSA)
PF10417
(1-cysPrx_C) 		5 VAL A  69
VAL A  71
ASP A 129
ILE A 134
TYR A 111
 None
 1.41A 6mxtA-1zyeA:
undetectable		 6mxtA-1zyeA:
18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e5a LIPOYLTRANSFERASE 1

(Bos taurus) 		no annotation 5 VAL A  80
VAL A  47
HIS A 150
ILE A  87
ASN A  88
 LAQ  A2001 ( 3.6A)
LAQ  A2001 ( 4.8A)
None
None
LAQ  A2001 ( 4.4A)
 1.38A 6mxtA-2e5aA:
undetectable		 6mxtA-2e5aA:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ex5 DNA ENDONUCLEASE
I-CEUI

(Chlamydomonas
moewusii) 		PF00961
(LAGLIDADG_1) 		5 VAL A 107
PHE A 140
PHE A  89
TYR A 141
ILE A 138
 None
 1.44A 6mxtA-2ex5A:
0.9		 6mxtA-2ex5A:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f7v AECTYLCITRULLINE
DEACETYLASE

(Xanthomonas
campestris) 		PF01546
(Peptidase_M20)
PF07687
(M20_dimer) 		5 VAL A 330
VAL A 153
PHE A 314
HIS A 340
ILE A 168
 None
 1.43A 6mxtA-2f7vA:
undetectable		 6mxtA-2f7vA:
22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w1j PUTATIVE SORTASE

(Streptococcus
pneumoniae) 		PF04203
(Sortase) 		5 VAL A 154
ASP A 150
PHE A 152
PHE A 140
ILE A  90
 None
 1.17A 6mxtA-2w1jA:
undetectable		 6mxtA-2w1jA:
18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wgh RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
LARGE SUBUNIT

(Homo sapiens) 		PF00317
(Ribonuc_red_lgN)
PF02867
(Ribonuc_red_lgC) 		5 VAL A 443
HIS A 200
ILE A 483
ASN A 484
TYR A 486
 None
 1.42A 6mxtA-2wghA:
undetectable		 6mxtA-2wghA:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zyj ALPHA-AMINODIPATE
AMINOTRANSFERASE

(Thermus
thermophilus) 		PF00155
(Aminotran_1_2) 		5 VAL A 352
PHE A 326
TYR A 205
ILE A 169
ASN A 174
 None
None
PGU  A 500 (-4.5A)
PGU  A 500 ( 4.3A)
PGU  A 500 (-3.5A)
 1.09A 6mxtA-2zyjA:
undetectable		 6mxtA-2zyjA:
22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cf4 ACETYL-COA
DECARBOXYLASE/SYNTHA
SE ALPHA SUBUNIT
ACETYL-COA
DECARBOXYLASE/SYNTHA
SE EPSILON SUBUNIT

(Methanosarcina
barkeri;
Methanosarcina
barkeri) 		PF03063
(Prismane)
PF02552
(CO_dh) 		5 VAL A 653
HIS A 734
TYR G  84
ILE G  85
ASN G  86
 None
ACY  A 818 (-3.8A)
ACY  A 818 ( 4.9A)
None
None
 1.49A 6mxtA-3cf4A:
undetectable		 6mxtA-3cf4A:
18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kf3 INVERTASE

(Schwanniomyces
occidentalis) 		PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C) 		5 VAL A 116
PHE A  55
PHE A 161
HIS A  84
TYR A  66
 None
 1.33A 6mxtA-3kf3A:
undetectable		 6mxtA-3kf3A:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3khy PROPIONATE KINASE

(Francisella
tularensis) 		PF00871
(Acetate_kinase) 		5 VAL A 304
VAL A 300
PHE A 343
PHE A 319
ILE A 345
 None
 1.32A 6mxtA-3khyA:
undetectable		 6mxtA-3khyA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lf2 SHORT CHAIN
OXIDOREDUCTASE
Q9HYA2

(Pseudomonas
aeruginosa) 		PF13561
(adh_short_C2) 		5 VAL A  74
VAL A  68
PHE A 129
ILE A 141
ASN A  93
 None
NDP  A 301 (-3.6A)
None
None
None
 1.41A 6mxtA-3lf2A:
undetectable		 6mxtA-3lf2A:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lnb N-ACETYLTRANSFERASE
FAMILY PROTEIN

(Bacillus
anthracis) 		PF00797
(Acetyltransf_2) 		5 VAL A 121
ASP A 106
ASN A  73
ILE A 196
TYR A  88
 None
 1.22A 6mxtA-3lnbA:
undetectable		 6mxtA-3lnbA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ob8 BETA-GALACTOSIDASE

(Kluyveromyces
lactis) 		PF00703
(Glyco_hydro_2)
PF02836
(Glyco_hydro_2_C)
PF02837
(Glyco_hydro_2_N)
PF02929
(Bgal_small_N) 		5 VAL A 328
ASP A 312
PHE A 244
ILE A 209
TYR A  26
 None
 1.48A 6mxtA-3ob8A:
undetectable		 6mxtA-3ob8A:
17.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pds FUSION PROTEIN
BETA-2 ADRENERGIC
RECEPTOR/LYSOZYME

(Homo sapiens;
Escherichia
virus T4) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		10 TRP A 109
VAL A 114
ASP A 192
PHE A 193
PHE A 289
ASN A 293
TYR A 308
ILE A 309
ASN A 312
TYR A 316
 None
ERC  A1201 (-3.8A)
ERC  A1201 (-4.2A)
ERC  A1201 (-4.4A)
ERC  A1201 (-4.5A)
ERC  A1201 (-3.5A)
None
ERC  A1201 (-4.1A)
ERC  A1201 (-3.0A)
None
 0.67A 6mxtA-3pdsA:
33.8		 6mxtA-3pdsA:
57.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pds FUSION PROTEIN
BETA-2 ADRENERGIC
RECEPTOR/LYSOZYME

(Homo sapiens;
Escherichia
virus T4) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		5 TRP A 109
VAL A 114
PHE A 289
ASN A 293
TYR A 308
 None
ERC  A1201 (-3.8A)
ERC  A1201 (-4.5A)
ERC  A1201 (-3.5A)
None
 1.39A 6mxtA-3pdsA:
33.8		 6mxtA-3pdsA:
57.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pds FUSION PROTEIN
BETA-2 ADRENERGIC
RECEPTOR/LYSOZYME

(Homo sapiens;
Escherichia
virus T4) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		10 TRP A 109
VAL A 114
VAL A 117
ASP A 192
PHE A 193
PHE A 289
ASN A 293
TYR A 308
ASN A 312
TYR A 316
 None
ERC  A1201 (-3.8A)
None
ERC  A1201 (-4.2A)
ERC  A1201 (-4.4A)
ERC  A1201 (-4.5A)
ERC  A1201 (-3.5A)
None
ERC  A1201 (-3.0A)
None
 0.71A 6mxtA-3pdsA:
33.8		 6mxtA-3pdsA:
57.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wbk EUKARYOTIC
TRANSLATION
INITIATION FACTOR 5B

(Saccharomyces
cerevisiae) 		PF00009
(GTP_EFTU)
PF03144
(GTP_EFTU_D2)
PF11987
(IF-2) 		5 VAL A 355
VAL A 379
ASP A 441
PHE A 443
ILE A 436
 None
 1.27A 6mxtA-3wbkA:
undetectable		 6mxtA-3wbkA:
23.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wp5 CDBFV

(Neocallimastix
patriciarum) 		PF00457
(Glyco_hydro_11) 		5 VAL A 199
VAL A 221
PHE A  48
HIS A   9
ILE A  24
 None
 1.23A 6mxtA-3wp5A:
undetectable		 6mxtA-3wp5A:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cp8 ALLOPHANATE
HYDROLASE

(Pseudomonas sp.
ADP) 		PF01425
(Amidase) 		5 VAL A 240
VAL A 237
PHE A  88
HIS A 115
ILE A  94
 None
 1.40A 6mxtA-4cp8A:
undetectable		 6mxtA-4cp8A:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d8m PESTICIDAL CRYSTAL
PROTEIN CRY5BA

(Bacillus
thuringiensis) 		PF03944
(Endotoxin_C)
PF03945
(Endotoxin_N) 		5 PHE A 197
ASN A 201
HIS A 243
TYR A 247
ILE A 251
 None
 1.08A 6mxtA-4d8mA:
2.5		 6mxtA-4d8mA:
21.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gbr BETA-2 ADRENERGIC
RECEPTOR

(Homo sapiens) 		PF00001
(7tm_1) 		6 ASP A 192
HIS A 268
TYR A 280
ILE A 281
ASN A 284
TYR A 288
 None
None
None
None
CAU  A 500 (-3.3A)
CAU  A 500 (-4.6A)
 1.33A 6mxtA-4gbrA:
34.3		 6mxtA-4gbrA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gbr BETA-2 ADRENERGIC
RECEPTOR

(Homo sapiens) 		PF00001
(7tm_1) 		7 TRP A 109
ASP A 192
PHE A 261
ASN A 265
TYR A 280
ILE A 281
TYR A 288
 None
None
CAU  A 500 (-4.2A)
CAU  A 500 (-3.4A)
None
None
CAU  A 500 (-4.6A)
 0.87A 6mxtA-4gbrA:
34.3		 6mxtA-4gbrA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gbr BETA-2 ADRENERGIC
RECEPTOR

(Homo sapiens) 		PF00001
(7tm_1) 		7 TRP A 109
ASP A 192
PHE A 261
TYR A 280
ILE A 281
ASN A 284
TYR A 288
 None
None
CAU  A 500 (-4.2A)
None
None
CAU  A 500 (-3.3A)
CAU  A 500 (-4.6A)
 0.79A 6mxtA-4gbrA:
34.3		 6mxtA-4gbrA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gbr BETA-2 ADRENERGIC
RECEPTOR

(Homo sapiens) 		PF00001
(7tm_1) 		8 TRP A 109
VAL A 114
ASP A 192
PHE A 193
PHE A 261
TYR A 280
ASN A 284
TYR A 288
 None
CAU  A 500 (-3.5A)
None
CAU  A 500 (-4.5A)
CAU  A 500 (-4.2A)
None
CAU  A 500 (-3.3A)
CAU  A 500 (-4.6A)
 0.74A 6mxtA-4gbrA:
34.3		 6mxtA-4gbrA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gbr BETA-2 ADRENERGIC
RECEPTOR

(Homo sapiens) 		PF00001
(7tm_1) 		9 TRP A 109
VAL A 114
VAL A 117
ASP A 192
PHE A 193
PHE A 261
ASN A 265
TYR A 280
TYR A 288
 None
CAU  A 500 (-3.5A)
CAU  A 500 (-4.2A)
None
CAU  A 500 (-4.5A)
CAU  A 500 (-4.2A)
CAU  A 500 (-3.4A)
None
CAU  A 500 (-4.6A)
 0.78A 6mxtA-4gbrA:
34.3		 6mxtA-4gbrA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ib4 CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 2B AND E.
COLI SOLUBLE
CYTOCHROME B562

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		5 TRP A 131
VAL A 136
PHE A 340
ASN A 344
TYR A 370
 None
ERM  A2001 (-3.8A)
ERM  A2001 (-4.3A)
ERM  A2001 (-4.3A)
ERM  A2001 ( 4.8A)
 0.59A 6mxtA-4ib4A:
28.4		 6mxtA-4ib4A:
25.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idi ORYZA SATIVA
RURM1-RELATED

(Plasmodium
yoelii) 		PF09138
(Urm1) 		5 VAL A  71
VAL A  25
ASP A  83
PHE A  42
ILE A  40
 None
 1.44A 6mxtA-4idiA:
undetectable		 6mxtA-4idiA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iu2 CELL-WALL ANCHORING
PROTEIN

(Ruminococcus
flavefaciens) 		PF00963
(Cohesin) 		5 ASP A  14
ASN A 107
HIS A  72
TYR A  74
ASN A 109
 None
 1.33A 6mxtA-4iu2A:
undetectable		 6mxtA-4iu2A:
18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ix8 TYROSINE
AMINOTRANSFERASE

(Leishmania
infantum) 		PF00155
(Aminotran_1_2) 		5 VAL A 407
VAL A 409
PHE A 397
HIS A 446
ILE A 366
 None
 1.31A 6mxtA-4ix8A:
undetectable		 6mxtA-4ix8A:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kgb SUCCINYL-COA:3-KETOA
CID-COENZYME A
TRANSFERASE

(Drosophila
melanogaster) 		PF01144
(CoA_trans) 		5 ASP A 380
PHE A 382
PHE A  58
ASN A  84
ASN A 341
 None
 1.34A 6mxtA-4kgbA:
undetectable		 6mxtA-4kgbA:
22.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lde LYSOZYME, BETA-2
ADRENERGIC RECEPTOR

(Homo sapiens;
Escherichia
virus T4) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		5 TRP A1109
ASP A1192
HIS A1296
TYR A1308
ILE A1309
 None
None
None
None
P0G  A1401 (-4.1A)
 1.06A 6mxtA-4ldeA:
48.9		 6mxtA-4ldeA:
99.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lde LYSOZYME, BETA-2
ADRENERGIC RECEPTOR

(Homo sapiens;
Escherichia
virus T4) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		11 TRP A1109
VAL A1114
VAL A1117
ASP A1192
PHE A1193
PHE A1289
ASN A1293
TYR A1308
ILE A1309
ASN A1312
TYR A1316
 None
P0G  A1401 (-3.7A)
P0G  A1401 ( 4.4A)
None
P0G  A1401 (-3.8A)
P0G  A1401 ( 4.7A)
P0G  A1401 (-3.0A)
None
P0G  A1401 (-4.1A)
P0G  A1401 (-2.9A)
None
 0.48A 6mxtA-4ldeA:
48.9		 6mxtA-4ldeA:
99.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m8u OLIGO-1,6-GLUCOSIDAS
E 1

(Bacillus
subtilis) 		PF00128
(Alpha-amylase)
PF16657
(Malt_amylase_C) 		5 VAL A 177
VAL A 181
ASP A 105
ASN A 101
TYR A  67
 None
 1.26A 6mxtA-4m8uA:
undetectable		 6mxtA-4m8uA:
20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n5q TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 3

(Mus musculus) 		PF00023
(Ank)
PF12796
(Ank_2) 		5 ASP A 156
PHE A 157
PHE A 193
ILE A 199
ASN A 197
 None
 1.07A 6mxtA-4n5qA:
undetectable		 6mxtA-4n5qA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4per ANGIOGENIN

(Gallus gallus) 		PF00074
(RnaseA) 		5 VAL B 102
ASP B   7
PHE B   8
ASN B  57
TYR B   5
 None
 1.38A 6mxtA-4perB:
undetectable		 6mxtA-4perB:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rae HISTIDINOL-PHOSPHATE
AMINOTRANSFERASE

(Mycobacterium
tuberculosis) 		PF00155
(Aminotran_1_2) 		5 VAL A 306
VAL A 314
ASP A 368
PHE A 358
TYR A 329
 None
 1.49A 6mxtA-4raeA:
undetectable		 6mxtA-4raeA:
22.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f8u BETA-1 ADRENERGIC
RECEPTOR

(Meleagris
gallopavo) 		no annotation 5 TRP B 117
VAL B 122
ASP B 200
PHE B 201
PHE B 307
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
None
P32  B 400 (-4.0A)
P32  B 400 (-4.9A)
 1.35A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f8u BETA-1 ADRENERGIC
RECEPTOR

(Meleagris
gallopavo) 		no annotation 5 TRP B 117
VAL B 122
VAL B 125
ASP B 200
PHE B 201
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
None
P32  B 400 (-4.0A)
 0.90A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f8u BETA-1 ADRENERGIC
RECEPTOR

(Meleagris
gallopavo) 		no annotation 8 TRP B 117
VAL B 122
VAL B 125
PHE B 201
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.75A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f8u BETA-1 ADRENERGIC
RECEPTOR

(Meleagris
gallopavo) 		no annotation 5 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.46A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jcg THIOREDOXIN-DEPENDEN
T PEROXIDE
REDUCTASE,
MITOCHONDRIAL

(Homo sapiens) 		PF00578
(AhpC-TSA)
PF10417
(1-cysPrx_C) 		5 VAL A  69
VAL A  71
ASP A 129
ILE A 134
TYR A 111
 None
 1.35A 6mxtA-5jcgA:
undetectable		 6mxtA-5jcgA:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jla PUTATIVE SHORT-CHAIN
DEHYDROGENASE/REDUCT
ASE

(Paraburkholderia
xenovorans) 		PF13561
(adh_short_C2) 		5 VAL A  68
VAL A  62
PHE A 124
ILE A 136
ASN A  87
 None
NAD  A 401 (-3.6A)
None
None
None
 1.47A 6mxtA-5jlaA:
undetectable		 6mxtA-5jlaA:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t5d PTS SYSTEM, IIB
COMPONENT

(Streptococcus
pneumoniae) 		PF03830
(PTSIIB_sorb) 		5 VAL A 144
ASP A  10
PHE A   5
ILE A   8
ASN A 102
 None
 1.20A 6mxtA-5t5dA:
undetectable		 6mxtA-5t5dA:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tus RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
LARGE SUBUNIT

(Homo sapiens) 		PF00317
(Ribonuc_red_lgN)
PF02867
(Ribonuc_red_lgC)
PF03477
(ATP-cone) 		5 VAL A 443
HIS A 200
ILE A 483
ASN A 484
TYR A 486
 None
 1.34A 6mxtA-5tusA:
0.0		 6mxtA-5tusA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wde KINESIN-LIKE PROTEIN
KIFC3

(Homo sapiens) 		PF00225
(Kinesin) 		5 VAL A 452
VAL A 745
ASP A 472
PHE A 471
ASN A 467
 None
None
UNX  A 909 ( 3.7A)
None
None
 1.42A 6mxtA-5wdeA:
undetectable		 6mxtA-5wdeA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6da0 GLUCOKINASE

(Naegleria
fowleri) 		no annotation 5 VAL A  53
VAL A  55
ASP A 143
PHE A 146
PHE A 136
 None
 1.46A 6mxtA-6da0A:
undetectable		 6mxtA-6da0A:
undetectable